The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research in JAMA Psychiatry ...

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Influencer and podcast maven Claudia Oshry used Ozempic to kickstart a newfound wellness journey.

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

Experts have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind. Several studies have linked the shots to conditions that cause inflammation and block blood ...

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging skin. Drinking water, eating a protein-rich diet, and practicing face yoga ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution ... Of course, pharmaceutical companies need to make profits on their hits because they also ...